Assessment of the Relationship Between Severity of Chronic Venous Obstruction and Venous Claudication
Launched by RWTH AACHEN UNIVERSITY · Dec 15, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the severity of chronic venous obstruction, which is a blockage in the veins that can cause problems with blood flow, relates to a condition called venous claudication. Venous claudication can cause pain or discomfort in the legs, especially when walking. The study aims to better understand how these two issues are connected, which could help improve treatment options for patients suffering from chronic venous insufficiency.
To participate in this trial, you need to be between 18 and 80 years old and have a specific blockage in one of the major veins in your body. You also need to be able to understand the study and give your consent to join. If you decide to participate, you can expect to undergo assessments related to your condition. This research is important as it may provide insights into better management of symptoms and improve quality of life for those affected by these vein issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with an obstruction in the femoral vein communis, V. iliaca externa, V. iliaca communis or V. cava inferior
- • 2. Age: 18-80 years old
- • 3. Signed informed consent form
- • 4. Persons who are legally competent and mentally capable, to follow the instructions of the staff
- Exclusion Criteria:
- • 1. Patients under 18 years of age.
- • 2. Patients who are unable to consent and/or not in are able to appreciate the nature, importance and scope of the study understand and give their consent in writing.
- • 3. Persons acting by administrative or judicial order are housed in a facility
- • 4. Patients who abuse drugs
- • 5. Peripheral arterial disease stage IIb, III and IV -
About Rwth Aachen University
RWTH Aachen University is a prestigious research institution located in Aachen, Germany, renowned for its commitment to advancing science and technology through innovative research and education. As a clinical trial sponsor, RWTH Aachen University leverages its interdisciplinary expertise and state-of-the-art facilities to conduct cutting-edge clinical research aimed at improving patient outcomes. The university collaborates with various healthcare stakeholders to facilitate the translation of scientific discoveries into effective therapeutic interventions, ensuring adherence to ethical standards and regulatory requirements throughout the research process. With a focus on fostering knowledge exchange and driving clinical advancements, RWTH Aachen University plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aachen, Nrw, Germany
Patients applied
Trial Officials
Houman Jalaie, MD
Principal Investigator
Universitätsklinikum Aachen Klinik für Gefäßchirurgie
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials